{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:33:22Z","timestamp":1773293602658,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jsat.2017.02.016","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T21:18:00Z","timestamp":1488316680000},"page":"101-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment"],"prefix":"10.1016","volume":"85","author":[{"given":"Allison G.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin S.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jsat.2017.02.016_bb0005","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies the COMBINE Study; A randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"Journal of the American Medical Association"},{"issue":"6","key":"10.1016\/j.jsat.2017.02.016_bb0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.clinthera.2005.06.015","article-title":"Acamprosate for the treatment of alcohol dependence","volume":"27","author":"Boothby","year":"2005","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1016\/j.jsat.2017.02.016_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1360-0443.2004.00763.x","article-title":"Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review","volume":"99","author":"Bouza","year":"2004","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.jsat.2017.02.016_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.trsl.2010.03.001","article-title":"Systematic review of the impact of adult drug-treatment courts","volume":"155","author":"Brown","year":"2010","journal-title":"Translational Research"},{"issue":"9","key":"10.1016\/j.jsat.2017.02.016_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technology Assessment"},{"issue":"5","key":"10.1016\/j.jsat.2017.02.016_bb0030","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1377\/hlthaff.2011.0501","article-title":"As roughly 700,000 prisoners are released annually, about half will gain health coverage and care under federal laws","volume":"31","author":"Cuellar","year":"2012","journal-title":"Health Affairs (Millwood)"},{"issue":"3","key":"10.1016\/j.jsat.2017.02.016_bb0035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.evalprogplan.2008.12.003","article-title":"Client and program factors associated with dropout from court mandated drug treatment","volume":"32","author":"Evans","year":"2009","journal-title":"Evaluation and Program Planning"},{"issue":"4","key":"10.1016\/j.jsat.2017.02.016_bb0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11414-011-9241-3","article-title":"High-risk offenders participating in court-supervised substance abuse treatment: Characteristics, treatment received, and factors associated with recidivism","volume":"38","author":"Evans","year":"2011","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"3","key":"10.1016\/j.jsat.2017.02.016_bb0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jsat.2011.04.003","article-title":"Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts","volume":"41","author":"Finigan","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.02.016_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.2010.05900.x","article-title":"Intramuscular extended-release naltrexone: Current evidence","volume":"1216","author":"Gastfriend","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.jsat.2017.02.016_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/002242780203900304","article-title":"The Baltimore City drug treatment court: One-year results from a randomized study","volume":"39","author":"Gottfredson","year":"2002","journal-title":"Journal of Research in Crime and Delinquency"},{"issue":"2","key":"10.1016\/j.jsat.2017.02.016_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1745-9133.2003.tb00117.x","article-title":"Effectiveness of drug treatment courts: evidence from a randomized trial","volume":"2","author":"Gottfredson","year":"2003","journal-title":"Criminology & Public Policy"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08897077.2011.616816","article-title":"Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime","volume":"33","author":"Gryczynski","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.02.016_bb0075","series-title":"Painting the current picture: A national report card on drug courts and other problem-solving court programs in the United States","author":"Huddleston","year":"2011"},{"key":"10.1016\/j.jsat.2017.02.016_bb0080","series-title":"Painting the current picture: A national report card on drug courts and other problem-solving court programs in the United States","author":"Huddleston","year":"2008"},{"issue":"10","key":"10.1016\/j.jsat.2017.02.016_bb0085","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1530-0277.2011.01523.x","article-title":"The efficacy of disulfiram for the treatment of alcohol use disorder","volume":"35","author":"J\u00f8rgensen","year":"2011","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2017.02.016_bb0090","series-title":"Correctional Populations in the United States, 2014","author":"Kaeble","year":"2015"},{"key":"10.1016\/j.jsat.2017.02.016_bb0095","series-title":"Substance dependence, abuse, and treatment of jail inmates, 2002. NCJ 209588","author":"Karberg","year":"2005"},{"issue":"3","key":"10.1016\/j.jsat.2017.02.016_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/17425251003641975","article-title":"Acamprosate","volume":"6","author":"Kennedy","year":"2010","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudsen","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2007.05.011","article-title":"Assessing the long-term impact of drug court participation on recidivism with generalized estimating equations","volume":"91","author":"Krebs","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"9776","key":"10.1016\/j.jsat.2017.02.016_bb0115","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicenter randomized trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0120","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08897077.2011.620475","article-title":"Buprenorphine-naloxone maintenance following release from jail","volume":"33","author":"Lee","year":"2012","journal-title":"Substance Abuse"},{"issue":"13","key":"10.1016\/j.jsat.2017.02.016_bb0125","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2017.02.016_bb0130","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1525\/fsr.2003.16.2.153","article-title":"A sober assessment of drug courts","volume":"16","author":"Marlowe","year":"2003","journal-title":"Federal Sentencing Reporter"},{"issue":"3","key":"10.1016\/j.jsat.2017.02.016_bb0135","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"8","author":"Mattick","year":"2009","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2017.02.016_bb0140","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.jsat.2017.02.016_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.02.016_bb0150","first-page":"CD001333","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"4","author":"Minozzi","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0155","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcrimjus.2011.11.009","article-title":"Assessing the effectiveness of drug courts on recidivism: A meta-analytic review of traditional and non-traditional drug court","volume":"40","author":"Mitchell","year":"2012","journal-title":"Journal of Criminal Justice"},{"issue":"1","key":"10.1016\/j.jsat.2017.02.016_bb0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/08897077.2015.1129389","article-title":"Community correctional agents' views of medication-assisted treatment: Examining their influence on treatment referrals and community supervision practices","volume":"37","author":"Mitchell","year":"2016","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.02.016_bb0165","series-title":"Drug use and dependence, state and federal prisoners, 2004. NCJ 213530","author":"Mumola","year":"2006"},{"key":"10.1016\/j.jsat.2017.02.016_bb0170","author":"National Association of Drug Court Professionals"},{"key":"10.1016\/j.jsat.2017.02.016_bb0175","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1098\/rstb.2008.0105","article-title":"Evidence-based treatments of addiction","volume":"363","author":"O'Brien","year":"2008","journal-title":"Philosophical Transactions of the Royal Society of London"},{"issue":"10","key":"10.1016\/j.jsat.2017.02.016_bb0180","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1530-0277.2011.01524.x","article-title":"Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence","volume":"35","author":"Pettinati","year":"2011","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1016\/j.jsat.2017.02.016_bb0185","series-title":"Director of substance abuse and correction services","author":"Robinson","year":"2016"},{"key":"10.1016\/j.jsat.2017.02.016_bb0190","first-page":"CD001867","article-title":"Opioid antagonists for alcohol dependence","volume":"12","author":"R\u00f6sner","year":"2010","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2017.02.016_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15288\/jsad.2012.73.413","article-title":"Advancing recovery: Implementing evidence-based treatment for substance use disorders at the systems level","volume":"73","author":"Schmidt","year":"2012","journal-title":"Journal of Studies on Alcohol and Drugs"},{"issue":"3","key":"10.1016\/j.jsat.2017.02.016_bb0200","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.drugalcdep.2011.08.026","article-title":"Strategies for evaluating the economic value of drugs in alcohol dependence treatment","volume":"122","author":"Schwappach","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.jsat.2017.02.016_bb0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcrimjus.2013.06.005","article-title":"Do drug courts reduce the use of incarceration?: A meta-analysis","volume":"41","author":"Sevigny","year":"2013","journal-title":"Journal of Criminal Justice"},{"key":"10.1016\/j.jsat.2017.02.016_bb0210","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ps.2009.60.6.761","article-title":"Prevalence of serious mental illness among jail inmates","volume":"60","author":"Steadman","year":"2009","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2017.02.016_bb0215","series-title":"NSDUH data review. Receipt of services for behavioral health problems: Results from the 2014 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.jsat.2017.02.016_bb0220","author":"Substance Abuse and Mental Health Services Administration"},{"issue":"9","key":"10.1016\/j.jsat.2017.02.016_bb0225","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00005053-200109000-00003","article-title":"Effects of involuntary outpatient commitment and depot antipsychotics on treatment adherence in persons with severe mental illness","volume":"189","author":"Swartz","year":"2001","journal-title":"The Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.jsat.2017.02.016_bb0230","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies \u2014 Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2017.02.016_bb0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/10550880902772456","article-title":"The cost effectiveness of naltrexone added to cognitive-behavioral therapy in the treatment of alcohol dependence","volume":"28","author":"Walters","year":"2009","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2017.02.016_bb0240","article-title":"The impact of drug treatment courts on recovery: A systematic review","volume":"493679","author":"Wittouck","year":"2013","journal-title":"The Scientific World Journal"},{"key":"10.1016\/j.jsat.2017.02.016_bb9000","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1099-176X(200006)3:2<97::AID-MHP77>3.0.CO;2-S","article-title":"Using randomized controlled trials to evaluate socially complex services: Problems, challenges and recommendations","volume":"3","author":"Wolff","year":"2000","journal-title":"The Journal of Mental Health Policy and Economics"},{"issue":"2","key":"10.1016\/j.jsat.2017.02.016_bb1000","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1258\/1355819011927224","article-title":"Randomised trials of socially complex interventions: Promise or peril?","volume":"6","author":"Wolff","year":"2001","journal-title":"Journal of Health Services Research & Policy"},{"issue":"10","key":"10.1016\/j.jsat.2017.02.016_bb0245","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpsyc.65.10.1214","article-title":"Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients","volume":"65","author":"Zarkin","year":"2008","journal-title":"Archives of General Psychiatry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216304755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:47:43Z","timestamp":1760039263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216304755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":51,"alternative-id":["S0740547216304755"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.02.016","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-release naltrexone and drug treatment courts: Policy and evidence for implementing an evidence-based treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}